Estilad® Touch, an exceptional soft tissue agent and filler, is expertly formulated for injections into the deep dermis and superficial layers of the subcutaneous tissue on the face. This versatile solution not only erases fine lines and wrinkles but also proves invaluable in the correction of various facial concerns, including cleft lip, scarring, and congenital eyelid malposition.

Fine Lines and Wrinkles: Achieve a smooth and youthful complexion as Estilad® Touch effectively removes fine lines and wrinkles.

Cleft Lip Correction: With precision injections, Estilad® Touch addresses and corrects cleft lip concerns, ensuring a harmonious facial profile.

Scarring Improvement: Estilad® Touch visibly reduces the appearance of scars, promoting skin revitalization and an even skin tone.

Congenital Eyelid Malposition: From eyelid retraction to euryblepharon, epiblepharon, and issues associated with a shallow orbit, Estilad® Touch offers comprehensive correction in the pretarsal and/or septal regions.

Estilad® Touch utilizes its advanced formulation to provide targeted enhancements, making it a go-to solution for both aesthetic refinement and corrective procedures. The injection process is designed for precision, allowing practitioners to address specific concerns with optimal control and natural-looking results.

Formulation:

Resorbable monophasic implant

HA Concentration:

Free Hyaluronic Acid 22 mg/ml

HA Origin:

Biofermentation, non-animal origin

Composition per ml:

Sodium hyaluronate 22 mg

Sodium chloride (NaCI) 9.0 mg

Disodium hydrogenphosphate (Na2HPO4.12H20) 0.555 mg

Sodium dihydrogenphosphate (NaH2PO4.1-120) 0.039 mg

Water for injection

Particle Size Range:

280—150 µm

BDDE (ppm):

Not more than 2 µg/g

Endotoxins (Eu/mg):

Less than 0.25 EU/mg

pH:

6.5-7.5

1 graduated sterile pre-filled syringes of 1 ml

1 x 1 ml and 1 needle 27 G